JAMA Network Open corrects a Supplement 2 name error in an IPMN chemotherapy study
A correction to Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms addresses a misspelled collaborator name in Supplement 2. The published record now reflects the correct spelling of Ahmet Bulent Dogrul’s name, and the article has been amended accordingly.
The change is narrow, but it sits inside a part of medical publishing where precision is not optional. In a peer-reviewed journal, a misspelled contributor name can interfere with indexing, attribution, and the integrity of the scholarly record. Even when the clinical findings of a study remain unchanged, the metadata around those findings still matters for authorship credit, searchability, citation tracking, and the permanent paper trail that follows a paper long after publication day.
Why a correction in supplementary material still matters
Supplemental files often contain the scaffolding around a study: expanded methods, additional analyses, or collaborator listings that do not always fit into the main text. Those files can be read less often than the primary article, yet they still belong to the record. When a collaborator’s name is wrong in a supplement, the error can persist in downloaded copies, citation managers, and secondary databases unless it is explicitly corrected.
For a condition such as intraductal papillary mucinous neoplasms, accurate documentation has real professional consequences. These pancreatic lesions sit at the intersection of gastroenterology, surgery, pathology, and oncology, and research in this area tends to involve distributed teams. A collaborator’s identification links the work to the correct investigator and institution, which affects professional credit and the traceability of contributions across future publications.
The correction also signals how seriously journals treat accuracy even in nonclinical details. In research medicine, a name error is not a cosmetic issue. It can alter the record of who participated in a study, and it can complicate the downstream systems that depend on exact text matching to assign credit.
The article’s subject remains unchanged
The corrected paper itself is an Original Investigation focused on Contemporary Adjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasms. No new clinical data, treatment effect, or endpoint change is described in the correction notice. The adjustment is limited to the spelling of a nonauthor collaborator’s name in Supplement 2.
That narrow scope matters. Readers should not infer a change in the study’s clinical interpretation, efficacy signals, or safety profile from this notice. The correction is administrative and bibliographic, not therapeutic. The paper’s scientific content remains as originally published, and the journal’s action restores the supplement to its intended form.
In practical terms, this kind of editorial repair protects the reliability of the published archive. A corrected supplement helps ensure that anyone consulting the paper later — whether for systematic review work, academic verification, or simple attribution — sees the accurate collaborator listing rather than a propagated error.
What this says about the research record
Medical literature is often judged by its headline results, but the support structure around those results is just as important. A pancreatic neoplasm study may influence how clinicians think about adjuvant treatment strategies, yet the paper’s legitimacy also depends on whether the names, affiliations, and supporting files are exact. Small inaccuracies in supplements can seem peripheral until they are copied into databases or cited in institutional records.
This correction shows a journal maintaining the quality of its published content at the level of individual names. That may sound modest, but it is part of the larger discipline of preserving an accurate scientific record. In a field where treatment decisions and research synthesis depend on trustworthy documents, even a single misspelling deserves correction.
The amendment also reflects a broader principle in academic medicine: the published version must match the true contribution history as closely as possible. When collaborator names are corrected promptly, the literature becomes easier to audit and less vulnerable to confusion across indexing systems, correspondence, and future citations.
Editorial precision remains part of clinical credibility
For clinicians and researchers reading the paper, the correction does not alter the evidence base for Intraductal Papillary Mucinous Neoplasms or the chemotherapy question under study. It does, however, reinforce the expectation that journals will fix even seemingly small errors when they surface. That expectation is central to trust in peer review and publication ethics.
The corrected record now avoids a preventable point of friction for the collaborator named in Supplement 2. It also reduces the risk that the misspelling will be repeated in derivative uses of the article. In a digital publishing environment, where one error can travel quickly across repositories and bibliographic tools, a formal correction is often the only reliable way to reset the record.
This notice is brief, and it should be read that way. It documents a specific spelling correction, nothing more. The scientific article remains focused on adjuvant chemotherapy in pancreatic intraductal papillary mucinous neoplasms, while the journal’s correction restores accuracy to the supporting material that surrounds it.